SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Peterson G.) srt2:(1995-1999)"

Sökning: WFRF:(Peterson G.) > (1995-1999)

  • Resultat 11-20 av 29
  • Föregående 1[2]3Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  •  
12.
  •  
13.
  •  
14.
  • Börjeson, Sussanne, 1962-, et al. (författare)
  • Similarities and differences in assessing nausea on a verbal category scale and a visual analogue scale.
  • 1997
  • Ingår i: Cancer Nursing. - 0162-220X .- 1538-9804. ; 20:4, s. 260-266
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>The use of verbal category scales in assessing patient symptoms is evolving, but the extent to which reliability and precision are lost in using them as opposed to a visual analogue scale (VAS) remains uncertain. The present study analyzed the concordance between a four-point verbal category scale and a VAS in assessing nausea intensity in patients undergoing chemotherapy. The analysis of a total of 348 simultaneous ratings by 104 women over four cycles revealed good concordance between the scales. The means of the VAS ratings (range 0-100 mm) corresponding to the four verbal categories divided the scale in four almost equally large parts (no nausea = 0.7, mild = 24.8, moderate = 48.3, severe = 75.1). However, the VAS ranges were wide. On an individual level a one-step change in the verbal category was associated with an average change of 20 mm on the VAS. The choice of scale to use should be based on the need in the particular situation. When measuring intensity of nausea in patients, the VAS is a reasonable choice due to its possibly greater ability to detect changes over time. On the group level, findings on a four-point category scale and a VAS on the average seem similar.</p>
  •  
15.
  • Dahlén, Inger, et al. (författare)
  • Inflammatory markers in acute exacerbations of obstructive pulmonary disease : predictive value in relation to smoking history
  • 1999
  • Ingår i: Respiratory Medicine. - 0954-6111 .- 1532-3064. ; 93:10, s. 744-751
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>The aim of this study was to investigate the relationship between the effect of emergency treatment and inflammatory markers in patients with acute exacerbations of obstructive pulmonary disease, especially with respect to smoking history. We investigated 50 unselected patients with acute bronchial obstruction. Blood, urine and sputum samples were taken and analysed for eosinophil and neutrophil markers. The patients were observed for at least 2 h and recordings of forced expiratory volume in 1 s (FEV1) were taken. They were re-examined after 1 and 4 weeks. The absolute levels of inflammatory markers did not differ significantly between non- or short-term smokers (&lt; or = 5 pack-years) and long-term smokers (&gt; 5 pack-years) with the exception of myeloperoxidase in serum (S-MPO), which was higher in long-term smokers. The patients with higher levels of eosinophil markers before emergency treatment experienced a greater improvement in lung function. In non- or short-term smokers this relationship was found in blood and urine, whereas in long-term smokers it was seen in sputum. No correlation was found between neutrophil markers and changes in lung function. We conclude that patients with obstructive pulmonary disease with acute exacerbations and high levels of eosinophil markers respond well to treatment.</p>
  •  
16.
  •  
17.
  •  
18.
  •  
19.
  • Hursti, Timo J, et al. (författare)
  • Impact of tumour burden on chemotherapy-induced nausea and vomiting
  • 1996
  • Ingår i: BRITISH JOURNAL OF CANCER. - STOCKTON PRESS. - 0007-0920. ; 74:7, s. 1114-1119
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>We investigated how residual tumour burden after cytoreductive surgery was related to the occurrence of acute and delayed nausea and vomiting in 101 ovarian cancer patients receiving their first chemotherapy course. The anti-emetic treatment included ond</p>
  •  
20.
  • Hursti, T J, et al. (författare)
  • Impact of tumour burden on chemotherapy-induced nausea and vomiting.
  • 1996
  • Ingår i: British Journal of Cancer. - 0007-0920 .- 1532-1827. ; 74:7, s. 1114-1119
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>We investigated how residual tumour burden after cytoreductive surgery was related to the occurrence of acute and delayed nausea and vomiting in 101 ovarian cancer patients receiving their first chemotherapy course. The anti-emetic treatment included ondansetron combined with dexamethasone or placebo. After chemotherapy all patients received ondansetron only for 5 days. Two categories of tumour burden (TB) were formed according to the diameter of the greatest residual tumour (&lt; 2 cm = minimal TB and &gt; or = 2 cm = large TB). Self-reports of nausea and vomiting were obtained for 15 days. Other potential predictor variables were assessed and included in multivariate analyses. Patients with large compared with minimal TB had more delayed emesis, especially on days 2-7. They also had more acute nausea. The aggravating effect associated with large residual TB was more evident in patients &gt; or = 55 years. During the second week after the chemotherapy the occurrence of nausea was higher in patients &gt; or = 55 years than in those &lt; 55 years. This was seen primarily in patients with large residual TB. Predictors for no delayed emesis at all were anti-emetic treatment with dexamethasone, minimal tumour burden, low neuroticism and no history of motion sickness. The increased risk of "persistent' delayed nausea and vomiting seen in older patients with large tumour burden may have important clinical implications and warrants further attention.</p>
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-20 av 29
  • Föregående 1[2]3Nästa
 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy